Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022

INTRODUCTION: Reviews of randomized clinical trials (RCTs) in dementia with Lewy bodies (DLB) are essential for informing ongoing research efforts of symptomatic therapies and potentially disease-modifying therapies (DMTs). METHODS: We performed a systematic review of all clinical trials conducted u...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelnour, Carla, Gonzalez, Maria Camila, Gibson, Lucy L., Poston, Kathleen L., Ballard, Clive G., Cummings, Jeffrey L., Aarsland, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195935/
https://www.ncbi.nlm.nih.gov/pubmed/37017910
http://dx.doi.org/10.1007/s40120-023-00467-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195935/
https://www.ncbi.nlm.nih.gov/pubmed/37017910
http://dx.doi.org/10.1007/s40120-023-00467-8

Ejemplares similares